Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151486690> ?p ?o ?g. }
- W2151486690 endingPage "1820" @default.
- W2151486690 startingPage "1809" @default.
- W2151486690 abstract "The introduction of imatinib mesylate (IM) has revolutionized the treatment of chronic myeloid leukemia (CML). Although experience is too limited to permit evidence-based evaluation of survival, the available data fully justify critical reassessment of CML management. The panel therefore reviewed treatment of CML since 1998. It confirmed the value of IM (400 mg/day) and of conventional allogeneic hematopoietic stem cell transplantation (alloHSCT). It recommended that the preferred initial treatment for most patients newly diagnosed in chronic phase should now be 400 mg IM daily. A dose increase of IM, alloHSCT, or investigational treatments were recommended in case of failure, and could be considered in case of suboptimal response. Failure was defined at 3 months (no hematologic response [HR]), 6 months (incomplete HR or no cytogenetic response [CgR]), 12 months (less than partial CgR [Philadelphia chromosome-positive (Ph(+)) > 35%]), 18 months (less than complete CgR), and in case of HR or CgR loss, or appearance of highly IM-resistant BCR-ABL mutations. Suboptimal response was defined at 3 months (incomplete HR), 6 months (less than partial CgR), 12 months (less than complete CgR), 18 months (less than major molecular response [MMolR]), and, in case of MMolR loss, other mutations or other chromosomal abnormalities. The importance of regular monitoring at experienced centers was highlighted." @default.
- W2151486690 created "2016-06-24" @default.
- W2151486690 creator A5007755609 @default.
- W2151486690 creator A5015101485 @default.
- W2151486690 creator A5016147985 @default.
- W2151486690 creator A5018111458 @default.
- W2151486690 creator A5019949455 @default.
- W2151486690 creator A5020401806 @default.
- W2151486690 creator A5035535476 @default.
- W2151486690 creator A5035964802 @default.
- W2151486690 creator A5040941721 @default.
- W2151486690 creator A5042734609 @default.
- W2151486690 creator A5044224344 @default.
- W2151486690 creator A5049971021 @default.
- W2151486690 creator A5056405520 @default.
- W2151486690 creator A5072582820 @default.
- W2151486690 creator A5074115908 @default.
- W2151486690 creator A5075849003 @default.
- W2151486690 creator A5079181777 @default.
- W2151486690 creator A5090435894 @default.
- W2151486690 creator A5091433944 @default.
- W2151486690 date "2006-09-15" @default.
- W2151486690 modified "2023-10-15" @default.
- W2151486690 title "Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet" @default.
- W2151486690 cites W120419820 @default.
- W2151486690 cites W1430390330 @default.
- W2151486690 cites W1490418776 @default.
- W2151486690 cites W1560843430 @default.
- W2151486690 cites W1604111726 @default.
- W2151486690 cites W1761050310 @default.
- W2151486690 cites W1799579309 @default.
- W2151486690 cites W1963587085 @default.
- W2151486690 cites W1964261631 @default.
- W2151486690 cites W1965527326 @default.
- W2151486690 cites W1965553215 @default.
- W2151486690 cites W1967862257 @default.
- W2151486690 cites W1967920366 @default.
- W2151486690 cites W1968071128 @default.
- W2151486690 cites W1968892414 @default.
- W2151486690 cites W1969228079 @default.
- W2151486690 cites W1971427996 @default.
- W2151486690 cites W1975595356 @default.
- W2151486690 cites W1977728980 @default.
- W2151486690 cites W1978514731 @default.
- W2151486690 cites W1978526996 @default.
- W2151486690 cites W1983242807 @default.
- W2151486690 cites W1984160018 @default.
- W2151486690 cites W1987239635 @default.
- W2151486690 cites W1988446426 @default.
- W2151486690 cites W1988689365 @default.
- W2151486690 cites W1992781063 @default.
- W2151486690 cites W1993231178 @default.
- W2151486690 cites W1994220656 @default.
- W2151486690 cites W1994400524 @default.
- W2151486690 cites W1995675906 @default.
- W2151486690 cites W1996490450 @default.
- W2151486690 cites W1997432620 @default.
- W2151486690 cites W1997991070 @default.
- W2151486690 cites W1999277101 @default.
- W2151486690 cites W1999512374 @default.
- W2151486690 cites W1999614615 @default.
- W2151486690 cites W2001313342 @default.
- W2151486690 cites W2001523905 @default.
- W2151486690 cites W2002831484 @default.
- W2151486690 cites W2006917576 @default.
- W2151486690 cites W2008649212 @default.
- W2151486690 cites W2010791052 @default.
- W2151486690 cites W2011474502 @default.
- W2151486690 cites W2011672574 @default.
- W2151486690 cites W2012081403 @default.
- W2151486690 cites W2015077893 @default.
- W2151486690 cites W2015616444 @default.
- W2151486690 cites W2016086822 @default.
- W2151486690 cites W2016320589 @default.
- W2151486690 cites W2018279800 @default.
- W2151486690 cites W2019031643 @default.
- W2151486690 cites W2025950197 @default.
- W2151486690 cites W2026389791 @default.
- W2151486690 cites W2028959752 @default.
- W2151486690 cites W2030154801 @default.
- W2151486690 cites W2033727803 @default.
- W2151486690 cites W2035154687 @default.
- W2151486690 cites W2035287697 @default.
- W2151486690 cites W2035741037 @default.
- W2151486690 cites W2036625526 @default.
- W2151486690 cites W2037798465 @default.
- W2151486690 cites W2038204317 @default.
- W2151486690 cites W2039045990 @default.
- W2151486690 cites W2045180507 @default.
- W2151486690 cites W2045494872 @default.
- W2151486690 cites W2048258225 @default.
- W2151486690 cites W2052431402 @default.
- W2151486690 cites W2059568372 @default.
- W2151486690 cites W2062104581 @default.
- W2151486690 cites W2063319055 @default.
- W2151486690 cites W2063804742 @default.
- W2151486690 cites W2070299475 @default.
- W2151486690 cites W2070382898 @default.